Simparica Trio Dog Extra Large 88.1 - 132lbs Red

Upgrade your extra-large dog's protection with Simparica Trio Dog Extra Large 88.1 - 132lbs Red a flavorful monthly chew offering triple defense against fleas, ticks, intestinal worms, and deadly heartworm disease. Don't compromise on your pet's well-being upgrade today!

In stock

paypal visa mastercard applepay

Description heroicons/outline/chevron-down

Simparica Trio Dog Extra Large 88.1 - 132lbs Red

Simparica Trio Dog Extra Large 88.1 - 132lbs Red the epitome of cutting-edge canine care. Tailored for extra-large dogs weighing between 88.1 and 132lbs, this extraordinary product has ascended to the pinnacle of veterinary excellence as a trusted all-in-one protection. Simparica Trio isn't just a product; it's a revolution in pet care, seamlessly blending efficacy, convenience, and a host of extended benefits to redefine the standards of comprehensive health protection for your cherished four-legged companion.

 

Key Benefits:

  • Masterful Parasite Defense: Simparica Trio is a formidable fortress against the full spectrum of external and internal threats fleas, ticks, heartworms, and intestinal parasites. Its triple-action formula not only eradicates existing infestations but also proactively prevents future ones, delivering a holistic shield for your extra-large dog.
  • Year-Round Assurance: A single monthly dose of Simparica Trio ensures relentless protection throughout the year. The sustained efficacy disrupts the life cycles of parasites, providing an unwavering defense against the diverse range of external and internal threats your canine companion may encounter on their adventures.
  • Delightful Administering Experience: Administering protection becomes a joyous experience with Simparica Trio's delectable chewable tablet form. The irresistible flavor transforms the monthly health routine into a shared moment of delight, as your furry friend eagerly anticipates their dose.
  • Waterproof Resilience: Simparica Trio's water-resistant formula empowers your dog to embrace aquatic adventures without compromising treatment efficacy. Whether they indulge in puddle jumps or lake swims, Simparica Trio remains steadfast in delivering unwavering protection.

 

Why Simparica Trio is the World's Number 1 Selling All-in-One Protection for Extra Large Dogs?

Simparica Trio has garnered the trust of pet owners with cutting-edge science with an unwavering commitment to your pet's well-being. This extraordinary product boasts a unique trio of active ingredients sarolaner, moxidectin, and pyrantel each contributing to the eradication and prevention of various parasitic threats.

The orchestrated synergy of these ingredients represents a zenith in parasitic control, comprehensively addressing fleas, ticks, heartworms, and intestinal worms. Trusted by veterinarians and pet owners globally, Simparica Trio simplifies the management of multiple parasitic threats, offering an all-encompassing solution in one convenient monthly dose.

Simparica Trio Dog Extra Large 88.1 - 132lbs Red isn't just a purchase; it's a declaration of commitment to your canine companion's health and happiness. Choose the trusted all-in-one protection for extra-large dogs and elevate your dog's well-being to unparalleled heights. Opt for Simparica Trio because your dog deserves nothing short of extraordinary care and unparalleled protection.

More Information heroicons/outline/chevron-down

Animal Type Dog
Breed Size 89lbs Plus
Ingredients
  • Sarolaner
  • Moxidectin
  • Pyrantel
Directions for use
  • It can be given with or without food intake.
  • It's a small, hard, but chewable tablet.
Caution

Use with caution in dogs with a history of seizures. Simparica Trio contains sarolaner, a member of the isoxazoline class, which has been associated with neurologic adverse reactions including tremors, ataxia, and seizures in dogs with or without a history of neurologic disorders. The safe use of Simparica Trio has not been evaluated in breeding, pregnant, or lactating dogs. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.